Advances in Hematological Malignancies
Recent decades have witnessed remarkable strides in the area of hematological malignancies. Novel therapies such as targeted therapy, immunotherapies, and therapy are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering hope for more curative treatment options.